CHMP positive on GSK's meningitis vaccine
This article was originally published in Scrip
Executive Summary
The EU's CHMP has granted a positive opinion on GlaxoSmithKline's vaccine against invasive meningococcal disease Nimenrix (MenACWY-TT) for use in people aged over 12 months.